Skip to main content

Table 3 Rebleeding cases

From: Non-steroidal anti-inflammatory drug-induced enteropathy as a major risk factor for small bowel bleeding: a retrospective study

No. Indication for capsule endoscopy Cause of small bowel bleeding Final diagnosis Timing of rebleeding after diagnosis Specific therapy Treatment outcome
1 Bloody stool Ulcer Crohn’s disease 23 days Thiopurine Persistent IDAc
2 Bloody stool Diffuse scar change Radiation ileitisa 87 days Surgery No further bleeding
3 Bloody stool Ulcer Crohn’s disease 117 days 5-aminosalicylic acid Persistent IDAc
4 Bloody stool Ulcer with stricture Radiation ileitisa 49 days Iron replacement Follow-up loss
5 IDA Ulcer Intestinal Tbcb 146 days Anti-Tbc medication Recovered IDA
6 IDA Ulcer with stricture NSAID-induced enteropathy 15 days Surgery Recovered IDA
7 Bloody stool Angioectasia Angioectasia 330 days Surgery No further bleeding
  1. a Indication for radiation therapy was uterine cervical cancer
  2. b The patient who was considered as having Crohn’s disease initially, presented with multiple lymphadenopathy and was finally diagnosed with tuberculosis
  3. cPatient No.1 was given methotrexate instead of thiopurine and no recurrence of anemia has been reported since then; Patient No.3 underwent resection of a short segment of the small bowel and anemia has not recurred so far
  4. IDA Iron deficiency anemia; Tbc Tuberculosis; NSAID Nonsteroidal anti-inflammatory drug